Form 4: United Therapeutics EVP Paul Mahon Executes Stock Options and Sells Shares
SEC Form 4
Paul Mahon, EVP & General Counsel of United Therapeutics, exercised stock options and sold shares on May 15, 2025, according to a pre-arranged 10b5-1 plan.
Summary
- On May 15, 2025, Paul A. Mahon, EVP & General Counsel of United Therapeutics Corporation, exercised stock options for 11,000 shares of common stock at a price of $117.76 per share.
- Mahon then sold a total of 11,000 shares in multiple transactions at prices ranging from $293.3142 to $302.02.
- These transactions were executed under a pre-arranged 10b5-1 trading plan established on December 24, 2024.
- Following these transactions, Mahon directly owns 36,781 shares of United Therapeutics common stock.
Sentiment
Score: 5
Explanation: Neutral sentiment as the transactions are part of a pre-planned trading strategy (10b5-1 plan) and do not necessarily reflect a change in the insider's view of the company's prospects.
Positives
- The transactions were executed under a pre-arranged 10b5-1 trading plan, which is a legal and transparent way for insiders to trade company stock.
Industry Context
Insider transactions are common and closely monitored, providing insights into management's perspective on the company's valuation and future prospects. A 10b5-1 plan indicates a pre-arranged strategy, mitigating concerns about trading on inside information.
Stakeholder Impact
- The sale of shares by an executive could be perceived negatively by some shareholders, but the existence of a 10b5-1 plan mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| 12/24/2024 | Date of pre-arranged 10b5-1 plan entered into by the reporting person |
| 03/15/2021 | Date exercisable for stock option |
| 05/15/2025 | Date of transaction (exercise of stock options and sale of shares) |
| 03/15/2027 | Expiration date for stock option |
| 05/16/2025 | Date of signature |
Keywords
Form 4, insider trading, stock options, share sale, Paul Mahon, United Therapeutics, UTHR, 10b5-1 plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.